Jeremy Scott Evans - 05 Mar 2026 Form 4 Insider Report for HELIOS TECHNOLOGIES, INC. (HLIO)

Role: Chief Financial Officer
Signature: /s/ Marc Greenberg, Attorney-in-Fact for Jeremy Scott Evans
Issuer symbol: HLIO
Transactions as of: 05 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 09 Mar 2026, 16:04:14 UTC
Previous filing: 06 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Evans Jeremy Scott	Chief Financial Officer	C/O HELIOS TECHNOLOGIES, INC., 7456 16TH ST E, SARASOTA	/s/ Marc Greenberg, Attorney-in-Fact for Jeremy Scott Evans	09 Mar 2026	0002087711

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HLIO	Restricted Stock Units	Award		+3,772		$0.000000^*	3,772	05 Mar 2026	Common Stock	3,772	$0.000000	Direct	F1
transaction	HLIO	Performance Stock Options (right to buy)	Award		+7,806		$0.000000^*	7,806	05 Mar 2026	Common Stock	7,806	$67.61	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each RSU represents the right to receive, following vesting, one share of Common Stock. Unless earlier forfeited under the terms of the RSU, 33-1/3% of the awards vest and convert into Common Stock on each of January 3, 2027, January 3, 2028, and January 3, 2029.
F2	The performance stock options granted to the reporting person on March 5, 2026, represent the right to receive, following vesting, a number of stock options up to 225% of the number of stock options. The number of performance stock options acquired upon vesting is contingent upon the achievement of pre-established performance metrics, as approved by the Company's Compensation Committee, over a three-year performance period beginning on the first day of the fiscal year of 2026 and ending the last day of the fiscal year of 2028, subject to continuous employment with the Company through March 15, 2029. Stock options expire 10 years from the date of grant.

Content

Each RSU represents the right to receive, following vesting, one share of Common Stock. Unless earlier forfeited under the terms of the RSU, 33-1/3% of the awards vest and convert into Common Stock on each of January 3, 2027, January 3, 2028, and January 3, 2029.

The performance stock options granted to the reporting person on March 5, 2026, represent the right to receive, following vesting, a number of stock options up to 225% of the number of stock options. The number of performance stock options acquired upon vesting is contingent upon the achievement of pre-established performance metrics, as approved by the Company's Compensation Committee, over a three-year performance period beginning on the first day of the fiscal year of 2026 and ending the last day of the fiscal year of 2028, subject to continuous employment with the Company through March 15, 2029. Stock options expire 10 years from the date of grant.